The use of moexipril in postmenopausal women with hypertension and associated changes of bone mineral density

Kardiologiya

Volumn 45, Issue 7, 2005, Pages 34-37

  Kirichehko, A A ^a   Demelkhanova, T S ^a   Ryazantsev, A A ^a   Novichkova, Yu N ^a   Ebzeeva, E Yu ^a   Yurchenko, K V ^a  

^a NONE

Author keywords

Bone density; Hypertension; Moexipril; Women, postmenopausal

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MOEXIPRIL; TETRAHYDROISOQUINOLINE DERIVATIVE;

ARTICLE; BLOOD PRESSURE; BONE DENSITY; CLIMACTERIUM; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICAL ANALYSIS; TIME; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; BONE DENSITY; CLIMACTERIC; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; TETRAHYDROISOQUINOLINES; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745253143     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Celia M. Oakley. Overview. In: Hypertension in Postmenopausal Women. Eds. H. F. Messerli, F.C. Aepfelbach. New York: Marsel Dekker 1996;1-11.
2. Harrison-Bernard L.M., Raij L. Postmenopausal hypertension. Curr Hypertens Rep 2000;2:2:202-207.
3. Cohen E., Wheat M.E., Swiderski D.M., Charney P. Hypertension in women. In: Hypertension: Pathophysiology, Diagnosis and Management. Eds. J.H. Laragh, B.M. Brenner. Second Ed. Raven Press 1995;159-169.
4. Fisman E.Z., Tenenbaum A., Pines A. Systemic hypertension in postmenopausal women: a clinical approach. Curr Hypertens Rep 2002;4:6:464-470.
5. Hatton K., Stimpel M., Chamders T. The effect of angiotensin I and bradykinin in the presence and absence of moexipril, and angiotensin 2 on osteoclast formation and activity. Submitted for publication.
6. Stimpel M. Hypertension after Menopause. 1997;85-91.